Alpha-linolenic acid (ALA) is inversely related to development of adiposity in school-age children

Eur J Clin Nutr. 2015 Feb;69(2):167-72. doi: 10.1038/ejcn.2014.210. Epub 2014 Oct 1.

Abstract

Background/objectives: Studies in adults indicate that dietary polyunsaturated fatty acid (PUFA) composition may play a role in development of adiposity. Because adipocyte quantity is established between late childhood and early adolescence, understanding the impact of PUFAs on weight gain during the school-age years is crucial to developing effective interventions.

Subjects/methods: We quantified N-3 and N-6 PUFAs in serum samples of 668 Colombian schoolchildren aged 5-12 years at the time of recruitment into a cohort study, using gas-liquid chromatography. Serum concentrations of N-3 (alpha-linolenic acid (ALA), eicosapentaenoic acid, docosahexaenoic acid) and N-6 PUFAs (linoleic acid, gamma-linolenic acid, dihomo-gamma-linolenic acid, arachidonic acid) were determined as percentage total fatty acids. Children's anthropometry was measured annually for a median of 30 months. We used mixed-effects models with restricted cubic splines to construct population body mass index-for-age z-score (BAZ) growth curves for age- and sex-specific quartiles of each PUFA.

Results: N-3 ALA was inversely related to BAZ gain after adjustment for sex, baseline age and weight status, as well as household socioeconomic level. Estimated BAZ change between 6 and 14 years among children in the highest quartile of ALA compared with those in the lowest quartile was 0.45 (95% confidence interval: 0.07, 0.83) lower (P-trend=0.006).

Conclusions: N-3 ALA may be protective against weight gain in school-age children. Whether improvement in PUFA status reduces adiposity in pediatric populations deserves evaluation in randomized trials.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adiposity / drug effects
  • Body Mass Index*
  • Child
  • Child, Preschool
  • Cohort Studies
  • Colombia
  • Diet*
  • Dietary Fats / blood
  • Dietary Fats / pharmacology
  • Dietary Fats / therapeutic use
  • Fatty Acids / blood*
  • Fatty Acids / pharmacology
  • Fatty Acids / therapeutic use
  • Female
  • Humans
  • Male
  • Nutritional Status*
  • Pediatric Obesity / blood
  • Pediatric Obesity / prevention & control*
  • Weight Gain / drug effects*
  • alpha-Linolenic Acid / blood*
  • alpha-Linolenic Acid / pharmacology
  • alpha-Linolenic Acid / therapeutic use

Substances

  • Dietary Fats
  • Fatty Acids
  • alpha-Linolenic Acid